NSE filing, NSE: AATMAJ. Summary written from the filing by ALFA Finder's alert engine.
Aatmaj Healthcare Ltd: key numbers
- Share price
- ₹23.80
- Market cap
- ₹53.79 Cr
- Revenue (annual)
- ₹24.32 Cr
- Net profit (annual)
- ₹0.71 Cr
- P/E (TTM)
- 75.4×Sector 51.1×
- Promoter holding
- 64.48%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aatmaj Healthcare Ltd
All →Aatmaj Healthcare Board Meeting Date
Aatmaj Healthcare will hold a board meeting on October 29, 2026, to consider the company's un-audited standalone financial results for the half year ending September 30, 2026.
Aatmaj Healthcare Annual General Meeting
Aatmaj Healthcare Limited concluded its 12th Annual General Meeting on September 17, 2026. Shareholders adopted the audited financial statements for the year ended March 31, 2026.
Aatmaj Healthcare Annual General Meeting
Aatmaj Healthcare Limited's 12th Annual General Meeting is scheduled for September 17, 2026, to be conducted via video conferencing, with e-voting facilities for members.
Aatmaj Healthcare Investor Presentation: Key Takeaways
Aatmaj Healthcare reports strong Q1 FY27 results with revenue reaching ₹8.13 Cr and profits before tax/depreciation at ₹1.52 Cr. The company is focusing on network expansion and high-margin specialty services.
Aatmaj Healthcare Other Announcement
Aatmaj Healthcare Limited submitted its Integrated Filing Governance compliance report for the quarter ended June 30, 2026, in accordance with SEBI circular requirements.
Aatmaj Healthcare H1 FY26 Results: Net Profit ₹0.5 Cr, Up 66.7% YoY
Aatmaj Healthcare Ltd reported revenue from operations of ₹10.8 Cr (+27.1% YoY) and net profit of ₹0.5 Cr (+66.7% YoY) for H1 FY26.
- Key figure
- Net profit ₹0.5 Cr · +66.7% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.